Definitive studies for use of galantamine as a pre-treatment countermeasure again
Ended Project Grant Awarded Last action
- Award ID
- R44NS068049
- Recipient
-
Countervail Corporation UEI SSUMBWLMM4F3
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $2,803,263
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Originally
- Place of performance
- Charlotte, NC 28223, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$1 | |
| Amendment | $630,123 | |
| Amendment | $844,970 | |
| Amendment | $981,654 | |
| Original award | $346,517 |
Quick answers
Who received award R44NS068049?
R44NS068049 was awarded to Countervail Corporation by National Institutes of Health (Department of Health and Human Services) on September 1, 2010.
How much is award R44NS068049 worth?
$2,803,263 has been obligated on R44NS068049.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award